Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Gabriel Steg

Showing results (51-60 of 242) with videos related to

Pageof 25
Sort By:
Journal of the American College of Cardiology|July 2, 2016
Reply: Pulse Pressure and Cardiovascular DeathSenthil Selvaraj, P Gabriel Steg, Yedid Elbez, et al.
The American Journal of Cardiology|December 17, 2013
Frequency of the use of low- versus high-dose aspirin in dual antiplatelet therapy after percutaneous coronary intervention (from the Dual Antiplatelet Therapy study)Alexis Matteau, Robert W Yeh, Dean Kereiakes, et al.
Clinical Cardiology|July 20, 2010
Assessment of atherothrombosis and its treatment in Mexico: first-year data of the REACH RegistryEfraín Gaxiola, Luis Eng-Ceceña, Fernando Ortiz-Galván, et al.
International Journal of Cardiology|July 22, 2014
Inadequate heart rate control despite widespread use of beta-blockers in outpatients with stable CAD: findings from the international prospective CLARIFY registryMichal Tendera, Kim Fox, Roberto Ferrari, et al.
American Heart Journal|April 21, 2009
Fondaparinux versus Enoxaparin in non-ST-elevation acute coronary syndromes: short-term cost and long-term cost-effectiveness using data from the Fifth Organization to Assess Strategies in Acute Ischemic Syndromes Investigators (OASIS-5) trialMark J Sculpher, Greta Lozano-Ortega, Jennifer Sambrook, et al.
American Heart Journal|March 22, 2020
Interplay between PCI access site, anticoagulant agent, and bleeding: Insights from the REGULATE-PCI randomized trialGuillaume Marquis-Gravel, Zhen Huang, Steven L Zelenkofske, et al.
Journal of the American Heart Association|September 30, 2016
Angina and Future Cardiovascular Events in Stable Patients With Coronary Artery Disease: Insights From the Reduction of Atherothrombosis for Continued Health (REACH) RegistryAlon Eisen, Deepak L Bhatt, P Gabriel Steg, et al.
Clinical Cardiology|June 2, 2012
Atherothrombotic disease, traditional risk factors, and 4-year mortality in a Latin American population: the REACH RegistryCarlos Cantú-Brito, Erwin Chiquete, José L Ruiz-Sandoval, et al.
Critical Pathways in Cardiology|May 7, 2009
Cardiovascular ischemic event rates in outpatients with symptomatic atherothrombosis or risk factors in the united states: insights from the REACH RegistryKim A Eagle, Alan T Hirsch, Robert M Califf, et al.
Journal of Magnetic Resonance Imaging : JMRI|April 9, 2013
Cardiac diffusion-weighted MR imaging in recent, subacute, and chronic myocardial infarction: a pilot studyJean-Pierre Laissy, Virginia Gaxotte, Elisabeth Ironde-Laissy, et al.
Pageof 25

Showing results (51-60 of 242) with videos related to

Sort By:
Pageof 25
Journal of the American College of Cardiology|July 2, 2016
Reply: Pulse Pressure and Cardiovascular DeathSenthil Selvaraj, P Gabriel Steg, Yedid Elbez, et al.
The American Journal of Cardiology|December 17, 2013
Frequency of the use of low- versus high-dose aspirin in dual antiplatelet therapy after percutaneous coronary intervention (from the Dual Antiplatelet Therapy study)Alexis Matteau, Robert W Yeh, Dean Kereiakes, et al.
Clinical Cardiology|July 20, 2010
Assessment of atherothrombosis and its treatment in Mexico: first-year data of the REACH RegistryEfraín Gaxiola, Luis Eng-Ceceña, Fernando Ortiz-Galván, et al.
International Journal of Cardiology|July 22, 2014
Inadequate heart rate control despite widespread use of beta-blockers in outpatients with stable CAD: findings from the international prospective CLARIFY registryMichal Tendera, Kim Fox, Roberto Ferrari, et al.
American Heart Journal|April 21, 2009
Fondaparinux versus Enoxaparin in non-ST-elevation acute coronary syndromes: short-term cost and long-term cost-effectiveness using data from the Fifth Organization to Assess Strategies in Acute Ischemic Syndromes Investigators (OASIS-5) trialMark J Sculpher, Greta Lozano-Ortega, Jennifer Sambrook, et al.
American Heart Journal|March 22, 2020
Interplay between PCI access site, anticoagulant agent, and bleeding: Insights from the REGULATE-PCI randomized trialGuillaume Marquis-Gravel, Zhen Huang, Steven L Zelenkofske, et al.
Journal of the American Heart Association|September 30, 2016
Angina and Future Cardiovascular Events in Stable Patients With Coronary Artery Disease: Insights From the Reduction of Atherothrombosis for Continued Health (REACH) RegistryAlon Eisen, Deepak L Bhatt, P Gabriel Steg, et al.
Clinical Cardiology|June 2, 2012
Atherothrombotic disease, traditional risk factors, and 4-year mortality in a Latin American population: the REACH RegistryCarlos Cantú-Brito, Erwin Chiquete, José L Ruiz-Sandoval, et al.
Critical Pathways in Cardiology|May 7, 2009
Cardiovascular ischemic event rates in outpatients with symptomatic atherothrombosis or risk factors in the united states: insights from the REACH RegistryKim A Eagle, Alan T Hirsch, Robert M Califf, et al.
Journal of Magnetic Resonance Imaging : JMRI|April 9, 2013
Cardiac diffusion-weighted MR imaging in recent, subacute, and chronic myocardial infarction: a pilot studyJean-Pierre Laissy, Virginia Gaxotte, Elisabeth Ironde-Laissy, et al.
Pageof 25